Page results
-
This page provides information about the investigation of and surgery to treat cancer of the oesophagus.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This page is intended for patients who suffer from laryngeal dystonia (formerly known as spasmodic dysphonia) who might benefit from this therapy.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
The purpose of this page is to explain what an ectopic pregnancy is, what it means for your health, the different treatment options, risks involved in treatment, and potential risks in future pregnancies.
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements